Latest Research

D Soleimani et al, 2019. Dietary patterns in relation to hepatic fibrosis among patients with non-alcoholic fatty liver disease, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Volume 12

G Wiltberger et al, 2019. Protective effects of coffee consumption following liver transplantation for hepatocellular carcinoma in cirrhosis, Aliment Pharmacol Ther, Volume 49(6).

Y P Chen et al, A systematic review and a dose-response meta-analysis of coffee dose and non-alcoholic fatty liver disease, Clinical Nutrition, published online.

E A Hu et al, 2018. Coffee consumption and liver-related hospitalizations and deaths in the ARIC study, European Journal of Clinical Nutrition, published online.

A Tverdal et al, 2018. Coffee and Wine Consumption is Associated with Reduced Mortality from Alcoholic Liver Disease: Follow-up of 219,279 Norwegian men and women aged 30 - 67 years. Annals of Epidemiology, published online.

C L Chen et al, 2018. Association of coffee consumption and liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B: A 5-year population-based cohort study, J Formos Med Assoc, published online.

D Tomic et al, 2018. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies, European Journal of Gastroenterology and Hepatology, published online.

L J M Alferink et al, 2018. Potential Mechanisms Underlying the Role of Coffee in Liver Health, Semin Liver Dis, Volume 38 (3)

I Yaya et al, 2018. Impact of alcohol and coffee intake on risk of advanced liver fibrosis: a longitudinal analysis in HIV-HCV coinfected patients (ANRS HEPAVIH CO-13 Cohort, Nutrients, Volume 10 (6)

S Liangpunsakul et al, 2018. Interaction between the patatin-like phospholipase domain-containing protein 3 genotype and coffee drinking and the risk for acute alcoholic hepatitis, Hepatology Communications, Volume 2 (1).

This information is intended for Healthcare professional audiences.
Please consider the environment before printing.